Real Labs, Actual Decisions With Actionable Six Sigma Metrics

QuidelOrtho Announces Featured ADLM Session How can actionable, Six Sigma insights improve lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes. https://mma.prnewswire.com/media/2732815/QuidelOrtho_Corporation_Angela_Armato.jpg ADLM […]

STRETCH ZONE CELEBRATES GRAND OPENING IN MYSTIC, CT

Premier Assisted Stretching Franchise Welcomes Newest Location Under Local Leadership Stretch Zone, the nation's premier assisted-stretching brand featuring a patented strapping system on proprietary tables, is proud to announce the opening of its newest location in Mystic, CT. This emphasizes Stretch Zone's continuous expansion on the heels of their 400th location milestone, and is operated

Foodborne Illness Lawyer Files Third Lawsuit Filed Against El Tapatio

Foodborne illness lawyer Jory Lange filed a third lawsuit in the El Tapatio Giardia outbreak. “A dozen people who got Giardia food poisoning from El Tapatio have asked us to help them get compensation for their medical bills, lost wages, and the horrible ordeal they've gone through,” says foodborne illness lawyer Jory Lange. This is

McDermott Appoints Michael Martino, Farhad Nanji to Board of Directors

Michael McKelvy Named Chair of the BoardNeil Bruce Named Lead Independent Director McDermott International, Ltd today announced the appointments of Michael Martino, co-founder and principal of Mason Capital Management, LLC (Mason), and Farhad Nanji, co-founder of MFN Partners, LP, to the company's Board of Directors effective August 15, 2025. The company also announced the appointment

Main Street Announces Preliminary Estimate of Second Quarter 2025 Operating Results

Announces Second Quarter 2025 Earnings Release and Conference Call Schedule Main Street Capital Corporation (NYSE: MAIN) (“Main Street” or the “Company”) is pleased to announce its preliminary operating results for the second quarter of 2025 and its second quarter 2025 earnings release and conference call schedule. In commenting on the Company's preliminary operating results for

Camin Cargo Announces Strategic Alliance with Stewart Inter Sea, Expanding Its Load and Discharge Crude and Petroleum Inspection Offerings to West Africa

Camin Cargo Control Holdings, Inc. (“Camin Cargo”), a global provider of independent testing, inspection and certification (TIC) services to the energy industry, today announced it has formeda strategic alliance with Stewart InterSeato provideCamin Cargo's clients with seamlesscrude andpetroleuminspection and testing services inWest Africanports. Based in the UK, Stewart Inter Sea is anindependent marine cargo inspector

Recurrent Energy Secures $260 Million Financing for Blue Moon Solar Project in Kentucky

94 MW Solar Facility Holds Power Purchase Agreement with Constellation Recurrent Energy, a subsidiary of Canadian Solar Inc.(“Canadian Solar”) (NASDAQ: CSIQ) and a global developer, owner, and operator of solar and energy storage assets, announced today it has closed project financing and tax equity for Blue Moon Solar. U.S. Bank, through its subsidiary U.S. Bancorp

SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate

— Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant — Interim results from the Phase 1/2 trial expected by 2027, aimed at entering thehigh-immunogenicity vaccine market — “OurSKYCellflu platform with our adjuvanted vaccine experience will lay a strong foundation for future success.” SK bioscience, a global innovative

Saluda Medical Announces Full U.S. Launch of EVA™ Sensing Technology for Use with the EvokeĀ® SmartLoop™ System

New Clinical Data on EVA to be Presented at ASPN 2025 Annual Conference Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with chronic neurological conditions, today announced the full commercial launch of EVA, its next-generation sensing technology, in the United States

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a.m. CDT to review its fourth quarter and fiscal 2025 financial results. Access to the discussion may be obtained as follows: Time: 8:00 a.m.CDTDate: August 6, 2025Dial-in: 1-800-274-8461 or 1-203-518-9814 (for international callers)Conference

Scroll to Top